UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): ~~September~~October 266, 2016 (~~September~~October 216, 2016)

COMPASS DIVERSIFIED HOLDINGS

(Exact name of registrant as specified in its charter)



Delaware	001-34927	57-6218917
(State or other jurisdiction of incorporation)	(Commission File Number)	(I.R.S. Employer Identification No.)

COMPASS GROUP DIVERSIFIED

HOLDINGS LLC

(Exact name of registrant as specified in its charter)



Delaware	001-34926	20-3812051
(State or other jurisdiction of incorporation)	(Commission File Number)	(I.R.S. Employer Identification No.)

Sixty One Wilton Road

Second Floor

Westport, CT 06880

(Address of principal executive offices and zip code)

Registrant’s telephone number, including area code: (203) 221-1703

Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:



o	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Section ~~7 Regulation~~8 Other FDEvents

Item 7 8.01 ~~Regulation~~Other ~~FD Disclosure~~Events

~~On September 22, 2016,~~ Compass ~~Diversified Holdings (“Holdings”) issued a press release announcing that Compass~~ Group Diversified Holdings LLC ~~(the “Company,”~~ and ~~together~~Compass ~~with~~Diversified Holdings, ~~collectively~~(NYSE: “CODI~~,” “us” or “we”~~) ~~has entered into a definitive agreement and plan of merger~~ (~~“Agreement”) with a wholly owned subsidiary of Hill-Rom Holdings~~collectively, ~~Inc. (~~“~~Purchaser~~CODI”) ~~relating~~reported tothat CODI’s ~~majority~~will ~~owned~~make ~~subsidiary, Anodyne Medical Device, Inc., also doing business and known as Tridien Medical (“Tridien”), and consummated the merger contemplated by the Agreement, resulting in Tridien becoming~~ a ~~wholly~~cash ~~owned~~distribution ~~subsidiary~~ of ~~Purchaser~~$0.36 ~~Tridien~~per ~~was~~share ~~sold~~ for athe ~~total~~third ~~enterprise~~quarter ~~value~~ of ~~$25 million~~2016. ~~After~~The ~~the~~distribution ~~allocation~~is ofpayable ~~the~~on ~~sales~~October ~~price to non-controlling equityholders and the payment of transaction expenses~~27, ~~CODI~~2016 ~~received~~to ~~approximately~~shareholders ~~$21 million~~ of ~~proceeds~~record ~~from~~on the ~~sale~~close ~~at closing. This amount was in respect~~ of ~~its~~business ~~debt and equity interests in Tridien, which was acquired by CODI~~ on ~~August~~October 120, ~~2006, and the payment of accrued interest and fees~~2016. ~~CODI~~A ~~does~~copy ~~not expect to record a significant gain or loss as a result~~ of the ~~sale.~~press ~~The~~release ~~proceeds~~announcing ~~will~~such bedistribution ~~used~~is toattached ~~pay~~hereto ~~down~~as ~~outstanding~~Exhibit ~~debt under Tridien’s revolving credit facility with CODI~~99.1 Aand ~~copy of the press release~~ is ~~attached~~incorporated asby ~~Exhibit~~reference 99herein.1 ~~hereto.~~

The foregoing description of the press release is qualified in its entirety by reference to the complete text of the press release furnished as Exhibit 99.1 hereto, which is incorporated by reference herein. The information in this Item 7.01 and Exhibit 99.1 is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as shall be expressly set forth in such filing.

Section 9 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits

(d) Exhibits.

Exhibit		Description
99.1		Press Release of CODI dated September 22, 2016 announcing the sale of Tridien Medical.

99.1 Press Release of CODI dated October 6, 2016

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: September 26, 2016	COMPASS DIVERSIFIED HOLDINGS
Date: October 6, 2016	COMPASS DIVERSIFIED HOLDINGS
	By:	/s/ Ryan J. Faulkingham
		Ryan J. Faulkingham
		Regular Trustee

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: September 26, 2016	COMPASS GROUP DIVERSIFIED HOLDINGS LLC
Date: October 6, 2016	COMPASS GROUP DIVERSIFIED HOLDINGS LLC
	By:	/s/ Ryan J. Faulkingham
		Ryan J. Faulkingham
		Chief Financial Officer

Filing Compare · Compass Group Diversified Holdings LLC